Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
Clinical trial NCT04773678 · COMPLETED
Trial details
- NCT number
- NCT04773678
- Sponsor
- Connect Biopharm LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-11
- Primary completion
- 2023-08-05
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.